This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotech Merger Monday Doesn't Squash Biotech Bubble Debate

03/30/15 - 10:43 AM EDT

Neither of the deals announced Monday are blockbusters or particularly transformative. Both buyers have specific needs and went after small targets for large prices.

READ FULL POST

PTC Therapeutics CEO Liquidates Stock Ownership in His Own Company

03/24/15 - 10:39 AM EDT

Biotech CEOs are supposed to be cheerleaders for their stock, so it's noteworthy when a CEO's pocketbook indicates otherwise.

READ FULL POST

Celgene's Crohn's Disease Drug Candidate Highlighted in NEJM

03/18/15 - 05:00 PM EDT

Celgene will be starting phase III studies of mongersen in Crohn's disease -- designed to lead to the drug's approval -- by the middle of the year.

READ FULL POST

Esperion CEO Twitter Trolls His Larger, Cholesterol-Lowering Rivals

03/17/15 - 10:26 AM EDT

When a biotech CEO diverts from safe, bland corporate tweets to engage in some clever competitive trolling, I stand and applaud.

READ FULL POST

CTI BioPharma Discloses More Data on Myelofibrosis Drug in SEC Filing

03/13/15 - 09:36 AM EDT

The cross-trial comparison between CTI BioPharma's pacritinib and Incyte's Jakafi looks worse than expected.

READ FULL POST

U.K. Regulators Grant Early Access to Merck Skin Cancer Drug, but Where Is Northwest Bio?

03/11/15 - 10:45 AM EDT

Skin cancer patients in Britain can be treated with Merck's Keytruda before the cancer immunotherapy drug is approved there under a new early access plan announced Wednesday.

READ FULL POST

Ocular Therapeutix Eye-Pain Plug Benefits Still Unclear

03/10/15 - 10:17 AM EDT

Ocular hasn't conducted clinical trials that would demonstrate that OTX-DP is any better than eye drops in reducing swelling and pain in the eye.

READ FULL POST

Bristol-Myers' Cancer Immunotherapy Opdivo Wins Approval to Treat Lung Cancer

03/04/15 - 01:47 PM EST

The new Opdivo approval covers patients with squamous non-small cell lung cancer no longer responsive to chemotherapy, according to an announcement made the FDA.

READ FULL POST

MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter

03/02/15 - 08:15 AM EST

Afrezza is "modestly effective" at reducing blood glucose and its long-term safety is unknown, according to a review of the inhaled insulin published this week by The Medical Letter.

READ FULL POST

Ampio Too Busy to Tell Investors Results of Eye Drug Study

02/25/15 - 07:55 AM EST

Ampio Pharmaceuticals completed a clinical trial of its diabetic macular edema drug Optina in November, but it is just too busy to disclose results.

READ FULL POST

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs